| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Zante Greg is a Chief Financial Officer at Viking Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $7.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | VKTX Viking Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 97,839 | $18.00 | $1,761,310.29 | -24.7% | -9.8% | +299.7% | |
| Apr 3, 2023 | VKTX Viking Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 161,940 | $17.19 | $2,784,218.57 | -35.4% | -12.1% | +340.2% |